The Right to Cognitive Travel: Psychedelic Experience and Freedom of Movement

This Article argues that the law should protect a right to cognitive travel—the ability to navigate altered states of consciousness—grounded analogically in the constitutional right to travel. The author contends that existing justifications for psychedelic reform, such as medical utility or cognitive liberty, either protect too few interests or lack a workable limiting principle. The proposed right would subject the Controlled Substances Act's categorical prohibition of classic psychedelics to strict scrutiny, which the author argues it is unlikely to survive. The right permits regulation (age limits, licensing, purity standards) but not total prohibition, drawing on the Nation's history and tradition of protecting freedom of thought and self-directed movement.

Study at a glance

Abstract

The law has long protected movement through physical space. This Article asks whether it should also protect movement through mental space. Psychedelics are reemerging in law and culture after decades of prohibition, but the prevailing justifications for reform--medical utility, religious freedom, neurodiversity, free speech, and especially cognitive liberty--either protect too few or fail to supply a workable limiting principle. This Article proposes a right to cognitive travel, grounded analogically in the constitutional right to travel. Just as the right to travel permits regulation of physical movement but not its foreclosure, a parallel liberty interest should protect the ability to navigate altered states of consciousness. The travel framing reflects the structure of the psychedelic experience itself, commonly described across clinical, literary, and first-person accounts as a trip, voyage, or exploration of inner space. It also supplies a limiting principle that broader cognitive liberty theories lack: the right protects mental movement that preserves agency, not the intoxication and dependency that displace it. Drawing on the Nation's history and tradition--including limits on prohibition, the primacy of freedom of thought, and the deep roots of self-directed movement--this right would subject the Controlled Substances Act's categorical prohibition of the classic psychedelics (such as psilocybin and ayahuasca) to strict scrutiny, which it is unlikely to survive. The government's own accommodations--ranging from sacramental exemptions and licensed clinical to non-preempted state-level regimes--undermine any claim that no less restrictive alternatives will suffice. The right, however, is not a right to deregulation. As with its physical counterpart, age limits, screening, licensing, purity standards, and conduct rules are all permissible. Total prohibition is not.